Primary hyperoxaluria type 1: strategy for organ transplantation

Area of Science:

• Nephrology
• Genetics
• Hepatology

Background:

• Primary hyperoxaluria type 1 (PH1) is an inherited metabolic disorder.
• It stems from a deficiency in the liver enzyme alanine:glyoxylate aminotransferase.
• This deficiency causes excessive oxalate synthesis and deposition in kidneys, leading to kidney damage and systemic oxalosis.

Purpose of the Study:

• To review the current understanding of Primary hyperoxaluria type 1.
• To discuss diagnostic approaches and management strategies.
• To highlight the role of organ transplantation in treating PH1.

Main Methods:

• Diagnosis relies on clinical presentation, imaging (sonography), urinary oxalate and glycolate levels, and genetic testing.
• Management involves conservative measures and ultimately, organ transplantation.

Main Results:

• Diagnosis of PH1 is frequently delayed.
• Liver transplantation, either alone or combined with kidney transplantation, is the definitive treatment.
• Transplantation outcomes show survival rates comparable to kidney transplantation alone.

Conclusions:

• Early liver transplantation before systemic oxalosis improves outcomes.
• Simultaneous or sequential liver-kidney transplantation strategies are employed based on disease severity and donor availability.
• Organ transplantation significantly enhances patient quality of life and growth.